Elsevier Commits to Accelerate AI-Driven Science Across Europe

Elsevier, a global leader in advanced information and decision support in science and healthcare, today announced its pledge to the European Commission's AI in Science Enablers Initiative.

Elsevier's contribution spans complimentary access to its AI-powered research and clinical tools, funded research collaborations, and training for the next generation of AI-literate researchers and clinicians, reflecting the company's mission to help advance science and healthcare to advance human progress.

The pledge was announced at the AI in Science Summit in Dublin, which brought together over 1,000 participants from the research, technology, business, and policy communities to launch the Commission's initiative to mobilize private-sector and philanthropic support for European science.

Elsevier AI solutions

Elsevier will make available 4,000 complimentary licenses for European researchers, healthcare professionals and students:

• 1,000 LeapSpace™ licenses for early-career and senior researchers, alongside a proposed Europe-wide Challenge to be developed with the Commission. LeapSpace is a research-grade AI workspace that helps researchers carry out complex tasks across their complete workflows.

• 1,000 ClinicalKey AI licenses. ClinicalKey AI is an EHR and API-enabled clinical decision support tool designed to quickly surface the latest evidence at the point of care.

• 1,000 ClinicalKey Nursing AI licenses. ClinicalKey Nursing AI is a clinical AI tool built specifically for nurses and designed to support both point of care decision-making and professional growth across the nursing career journey.

• 1,000 Complete Anatomy licenses. Complete Anatomy is the world's most advanced 3D anatomy platform.

Research collaboration and training

• Alongside these licenses, Elsevier is committing an estimated €1m a year of in-kind support and funding to strengthen Europe's AI research talent pipeline and to advance responsible, AI-centered research:

• At least three new collaborations per year with European research institutions, drawing on in-kind support from Elsevier's data science, ethics and software development experts, alongside access to its content suite and knowledge discovery tools.

• Participation in the Horizon-funded AIRIS project, which supports AI-enabled hypothesis generation in biomedicine.

• Establishment of a new Centre on Hybrid Intelligence for Trustworthy Research, in partnership with the University of Amsterdam and Vrije Universiteit Amsterdam.

• Training and career development for approximately 10 PhD candidates, postdoctoral researchers and master’s students in AI per year, through programs across the company.

Kumsal Bayazit, CEO, Elsevier, said: “Europe's world-leading researchers and clinicians are working at the frontier of AI, and they need platforms and partnerships they can trust. Through this pledge, Elsevier is bringing the full breadth of its capabilities to that effort — funded collaborations, training for the next generation of scientists, and research-grade AI and clinical solutions for better outcomes. We're proud to support the European Commission's AI in Science Enablers Initiative and to help build an AI research ecosystem for Europe that is innovative, responsible, and sustainable.”

Elsevier will continue to work with the European Commission to refine the details of its pledge, including the scope of the LeapSpace Challenge, in the weeks following the Summit. To apply for complimentary access to Elsevier’s AI-powered research and clinical tools, please visit: www.elsevier.com/promotions/eu-ai-science-enablers-portal.

About the AI in Science Enablers Initiatives

The AI in Science Enablers Initiative is a European Commission initiative to maximize the impact of private-sector and philanthropic support for the European research community, and to make these initiatives as visible and accessible as possible to researchers and scientific organizations across Europe.

關於 Elsevier

身為科學資訊與分析的全球領導者，Elsevier 協助研究人員與醫療照護專業人員推動科學發展，改善醫療成果，造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎，透過創新的解決方案促進洞察力和關鍵決策。

140 多年來，我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工，包括 2,300 名技術人員，致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍，包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundationopens in new tab/window) 合作，與我們服務的社群攜手合作，在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELXopens in new tab/window 的一部分，RELXopens in new tab/window 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊，請造訪 www.elsevier.com 。